185 related articles for article (PubMed ID: 15670046)
21. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase.
Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP
Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303
[TBL] [Abstract][Full Text] [Related]
22. A novel thromboxane A2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis.
Mumford AD; Dawood BB; Daly ME; Murden SL; Williams MD; Protty MB; Spalton JC; Wheatley M; Mundell SJ; Watson SP
Blood; 2010 Jan; 115(2):363-9. PubMed ID: 19828703
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of original dual thromboxane A2 modulators as antiangiogenic agents.
de Leval X; Dassesse T; Dogné JM; Waltregny D; Bellahcène A; Benoit V; Pirotte B; Castronovo V
J Pharmacol Exp Ther; 2006 Sep; 318(3):1057-67. PubMed ID: 16720756
[TBL] [Abstract][Full Text] [Related]
24. Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology.
Nakahata N
Pharmacol Ther; 2008 Apr; 118(1):18-35. PubMed ID: 18374420
[TBL] [Abstract][Full Text] [Related]
25. Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses.
Nakashima S; Koike T; Nozawa Y
Mol Pharmacol; 1991 Apr; 39(4):475-80. PubMed ID: 2017148
[TBL] [Abstract][Full Text] [Related]
26. Residual cyclooxygenase-1 activity and epinephrine reduce the antiplatelet effect of aspirin in patients with acute myocardial infarction.
Moscardó A; Santos MT; Fuset MP; Ruano M; Vallés J
Thromb Haemost; 2011 Apr; 105(4):663-9. PubMed ID: 21301784
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and pharmacological evaluation of novel nitrobenzenic thromboxane modulators as antiplatelet agents acting on both the alpha and beta isoforms of the human thromboxane receptor.
Hanson J; Reynaud D; Qiao N; Devel P; Moray AL; Renard JF; Kelley LP; Winum JY; Montero JL; Kinsella BT; Pirotte B; Pace-Asciak CR; Dogné JM
J Med Chem; 2006 Jun; 49(12):3701-9. PubMed ID: 16759113
[TBL] [Abstract][Full Text] [Related]
28. I4, a new synthetic sulfonylurea compound, inhibits the action of TXA2 in vivo and in vitro on platelets and aorta vascular smooth muscle.
Lu N; Zhan M; Gao C; Wu G; Zhang H
Thromb Res; 2012 Oct; 130(4):e209-15. PubMed ID: 22909828
[TBL] [Abstract][Full Text] [Related]
29. Selective modulation of the human platelet thromboxane A2/prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact platelets and solubilized platelet membranes.
Parent CA; Lagarde M; Venton DL; Le Breton GC
J Biol Chem; 1992 Apr; 267(10):6541-7. PubMed ID: 1532390
[TBL] [Abstract][Full Text] [Related]
30. Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization.
Jin YR; Cho MR; Ryu CK; Chung JH; Yuk DY; Hong JT; Lee KS; Lee JJ; Lee MY; Lim Y; Yun YP
J Pharmacol Exp Ther; 2005 Jan; 312(1):214-9. PubMed ID: 15328379
[TBL] [Abstract][Full Text] [Related]
31. Residual platelet thromboxane A2 and prothrombotic effects of erythrocytes are important determinants of aspirin resistance in patients with vascular disease.
Santos MT; Valles J; Lago A; Tembl J; Sánchez E; Moscardo A; Cosin J
J Thromb Haemost; 2008 Apr; 6(4):615-21. PubMed ID: 18221358
[TBL] [Abstract][Full Text] [Related]
32. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation.
de Leval X; Benoit V; Delarge J; Julémont F; Masereel B; Pirotte B; Merville MP; David JL; Dogné JM
Prostaglandins Leukot Essent Fatty Acids; 2003 Jan; 68(1):55-9. PubMed ID: 12538091
[TBL] [Abstract][Full Text] [Related]
34. Homologous desensitization of signalling by the beta (beta) isoform of the human thromboxane A2 receptor.
Kelley-Hickie LP; Kinsella BT
Biochim Biophys Acta; 2006 Sep; 1761(9):1114-31. PubMed ID: 16956790
[TBL] [Abstract][Full Text] [Related]
35. Triplatin, a platelet aggregation inhibitor from the salivary gland of the triatomine vector of Chagas disease, binds to TXA(2) but does not interact with glycoprotein PVI.
Ma D; Assumpção TC; Li Y; Andersen JF; Ribeiro J; Francischetti IM
Thromb Haemost; 2012 Jan; 107(1):111-23. PubMed ID: 22159626
[TBL] [Abstract][Full Text] [Related]
36. TRA-418, a novel compound having both thromboxane A(2) receptor antagonistic and prostaglandin I(2) receptor agonistic activities: its antiplatelet effects in human and animal platelets.
Yamada N; Miyamoto M; Isogaya M; Suzuki M; Ikezawa S; Ohno M; Otake A; Umemura K
J Thromb Haemost; 2003 Aug; 1(8):1813-9. PubMed ID: 12911598
[TBL] [Abstract][Full Text] [Related]
37. In vitro platelet antiaggregatory properties of 4-methylcoumarins.
Macáková K; Řeháková Z; Mladěnka P; Karlíčková J; Filipský T; Říha M; Prasad AK; Parmar VS; Jahodář L; Pávek P; Hrdina R; Saso L
Biochimie; 2012 Dec; 94(12):2681-6. PubMed ID: 22996069
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of anti-platelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood.
Kariyazono H; Nakamura K; Arima J; Ayukawa O; Onimaru S; Masuda H; Iguro Y; Majima HJ; Sakata R; Yamada K
Blood Coagul Fibrinolysis; 2004 Mar; 15(2):157-67. PubMed ID: 15091003
[TBL] [Abstract][Full Text] [Related]
39. Thiamylal and pentobarbital have opposite effects on human platelet aggregation in vitro.
Sato M; Hirakata H; Nakagawa T; Arai K; Fukuda K
Anesth Analg; 2003 Nov; 97(5):1353-1359. PubMed ID: 14570651
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
Lewis GP; Watts IS
Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
